Trainings and Resources
19 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
A study published in the Journal of Appalachian Health examines whether there were higher levels of anxiety, fear, and depression among those who continued working outside the home compared with those who began working remotely during the shutdown. A separate article in the same issue, A Description of COVID-19 Lifestyle Restrictions Among a Sample of Rural Appalachian Women gives findings of a survey that asked about social interactions, doctor visits, child care, and substance use recovery.
Posted 12/23/2020 (updated 12/22/2020)
This toolkit is designed primarily for substance use and child welfare practitioners, as well as other service providers and health system planners who offer services to, or design services with, pregnant women and new mothers who use substances. Much is changing in the substance use and child welfare fields to bring forth approaches that are culturally safe, trauma informed, harm reduction-oriented and participant-driven. This toolkit highlights these advances and invites people working in both systems to think about how we can continue to improve our work, in partnership with the women who use these services.
Posted 12/16/2020 (updated 12/15/2020)
The curriculum focuses on the effects of substance abuse on families, parenting, and the parent-child relationship, incorporating Joan and Eric Erickson’s eight themes of growth spanning the life cycle and the Stone Center’s Self-in-Relation theory of women’s development. Combining experiential and didactic exercises, this approach is designed to enhance parents’ self-awareness and thereby increase understanding of their children.
Lessons Learned From Listening Sessions With Five Tribes in Minnesota.
Medications for opioid use disorder, including buprenorphine hydrochloride and methadone hydrochloride, are highly effective at improving outcomes for individuals with the disorder. For pregnant women, use of these medications also improves pregnancy outcomes, including the risk of preterm birth. Despite the known benefits of medications for opioid use disorder, many pregnant and nonpregnant women with the disorder are not receiving them.
Posted 7/10/2020 (updated 7/22/2020)
Communities of color have experienced significant disparities in health outcomes from COVID-19, as well as barriers to accessing testing. Predominantly white communities have had access to more testing sites than communities that are predominantly made up of Black and Latinx residents.
Prescription opioid use during pregnancy has been associated with poor outcomes for mothers and infants. Studies using administrative data have estimated that 14%–22% of women filled a prescription for opioids during pregnancy; however, data on self-reported prescription opioid use during pregnancy are limited.
The information in this document was guided by the vision of the U.S. Department of Health and Human Services’ Office on Women’s Health and lessons learned from a 3-year reentry enhancement project conducted across 3 different reentry organizations. The participating pilot sites were the Resonance Center for Women, Inc., the College and Community Fellowship, and the Institute for Health and Recovery . Using the information compiled through this project, this guide was created by the Substance Abuse and Mental Health Services Administration’s GAINS Center for Behavioral Health and Justice Transformation.
Violence against women is a global issue affecting millions who experience it and have to live with its consequences. Intimate partner violence (IPV) including physical, sexual and emotional abuse is a major public health problem. The WHO Violence Against Women study found that the prevalence of lifetime physical violence and sexual violence by an intimate partner, among ever-partnered women varied from 15 to 71% in urban and rural settings in 10 countries. The prevalence of IPV is higher among women seeking primary care than in community surveys of the same geographic populations.
The opioid epidemic has reached crisis levels, and its effects are especially apparent in rural communities. One consequence of the opioid epidemic is opioid-affected births. Non-medical opioid use during pregnancy has potential health consequences for pregnant women and their infants, yet little information is available about its prevalence and associated factors in rural communities. This brief presents data on rural-urban differences in non-medical opioid use among pregnant women to inform policy, programmatic, and clinical efforts to address this crisis.